Literature DB >> 16278047

Characterization of FBX25, encoding a novel brain-expressed F-box protein.

Olivier Hagens1, Eleonora Minina, Susann Schweiger, Hans-Hilger Ropers, Vera Kalscheuer.   

Abstract

F-box proteins (FBPs) confer substrate specificity to the SCF-type (Skp1/Cul1/FBP) of ubiquitin ligase complexes through their F-box. Multiple FBPs have been predicted, but experimental evidence is lagging. We report on the predicted human FBP hFBX25 which we found to be disrupted in a mentally retarded translocation carrier suffering from epileptic seizures. We investigated hFBX25's genomic organization and established hFBX25 as an FBP by verifying its interaction with Skp1 and Cul1. In the process, we identified an atypical serine residue in the F-box which is crucial for the hFBX25-Skp1 binding. We determined hFBX25's subcellular localization. We found strong transcription in human brain. In mouse embryonic sections, mFbx25 shows predominantly neuronal expression and in adult mouse brain, expression is confined to the hippocampus, the cerebral cortex and the Purkinje cell layer. Interestingly, aberrations in the ubiquitin pathway have been linked to neurological conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278047     DOI: 10.1016/j.bbagen.2005.09.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  FBXO25-associated nuclear domains: a novel subnuclear structure.

Authors:  Adriana O Manfiolli; Ana Leticia G C Maragno; Munira M A Baqui; Sami Yokoo; Felipe R Teixeira; Eduardo B Oliveira; Marcelo D Gomes
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

2.  FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.

Authors:  Gui-Yang Jiang; Xiu-Peng Zhang; Liang Wang; Xu-Yong Lin; Juan-Han Yu; En-Hua Wang; Yong Zhang
Journal:  Tumour Biol       Date:  2016-09-05

3.  Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis.

Authors:  Ursula Baumann; Vanesa Fernández-Sáiz; Martina Rudelius; Simone Lemeer; Roland Rad; Anna-Maria Knorn; Jolanta Slawska; Katharina Engel; Irmela Jeremias; Zhoulei Li; Viktoriya Tomiatti; Anna-Lena Illert; Bianca-Sabrina Targosz; Martin Braun; Sven Perner; Michael Leitges; Wolfram Klapper; Martin Dreyling; Cornelius Miething; Georg Lenz; Andreas Rosenwald; Christian Peschel; Ulrich Keller; Bernhard Kuster; Florian Bassermann
Journal:  Nat Med       Date:  2014-11-24       Impact factor: 53.440

4.  A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions.

Authors:  Wen Xue; Thomas Kitzing; Stephanie Roessler; Johannes Zuber; Alexander Krasnitz; Nikolaus Schultz; Kate Revill; Susann Weissmueller; Amy R Rappaport; Janelle Simon; Jack Zhang; Weijun Luo; James Hicks; Lars Zender; Xin Wei Wang; Scott Powers; Michael Wigler; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-07       Impact factor: 11.205

Review 5.  Ubiquitin-Mediated Control of ETS Transcription Factors: Roles in Cancer and Development.

Authors:  Charles Ducker; Peter E Shaw
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

6.  Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data.

Authors:  Christiaan Klijn; Henne Holstege; Jeroen de Ridder; Xiaoling Liu; Marcel Reinders; Jos Jonkers; Lodewyk Wessels
Journal:  Nucleic Acids Res       Date:  2008-01-10       Impact factor: 16.971

7.  Human subtelomeric duplicon structure and organization.

Authors:  Anthony Ambrosini; Sheila Paul; Sufen Hu; Harold Riethman
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

8.  Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C.

Authors:  Lucie Tosca; Loïc Drévillon; Aurélie Mouka; Laure Lecerf; Audrey Briand; Valérie Ortonne; Virginie Benoit; Sophie Brisset; Lionel Van Maldergem; Quitterie Laudouar; Solveig Heide; Michel Goossens; Irina Giurgea; Gérard Tachdjian; Corinne Métay
Journal:  Mol Genet Genomic Med       Date:  2021-09-28       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.